Central Pacific Bank Trust Division Increases Holdings in Encompass Health Co. (NYSE:EHC)

Central Pacific Bank Trust Division grew its stake in Encompass Health Co. (NYSE:EHC) by 15.1% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,195 shares of the company’s stock after acquiring an additional 418 shares during the quarter. Central Pacific Bank Trust Division’s holdings in Encompass Health were worth $295,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of the stock. UMB Bank n.a. increased its position in Encompass Health by 387.7% during the third quarter. UMB Bank n.a. now owns 317 shares of the company’s stock worth $31,000 after purchasing an additional 252 shares during the last quarter. V Square Quantitative Management LLC increased its holdings in shares of Encompass Health by 53.0% during the 3rd quarter. V Square Quantitative Management LLC now owns 404 shares of the company’s stock worth $39,000 after buying an additional 140 shares during the last quarter. Avior Wealth Management LLC purchased a new stake in shares of Encompass Health during the 3rd quarter valued at approximately $40,000. Benjamin F. Edwards & Company Inc. lifted its holdings in Encompass Health by 58.9% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company’s stock valued at $46,000 after acquiring an additional 198 shares during the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. purchased a new position in Encompass Health in the second quarter worth approximately $58,000. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on the company. Barclays lifted their target price on Encompass Health from $109.00 to $116.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Truist Financial reaffirmed a “buy” rating and issued a $116.00 target price (up previously from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. UBS Group boosted their price target on shares of Encompass Health from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, September 25th. Royal Bank of Canada increased their price objective on shares of Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Finally, KeyCorp boosted their target price on Encompass Health from $115.00 to $117.00 and gave the company an “overweight” rating in a research report on Tuesday, October 29th. Nine research analysts have rated the stock with a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average target price of $107.11.

Encompass Health Stock Down 0.7 %

Encompass Health stock opened at $91.18 on Friday. The firm has a market capitalization of $9.19 billion, a P/E ratio of 22.02, a P/E/G ratio of 1.30 and a beta of 0.86. The stock’s fifty day simple moving average is $98.90 and its 200-day simple moving average is $93.47. Encompass Health Co. has a twelve month low of $66.36 and a twelve month high of $104.55. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88.

Encompass Health (NYSE:EHC) last issued its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping the consensus estimate of $0.94 by $0.09. The company had revenue of $1.35 billion for the quarter, compared to the consensus estimate of $1.33 billion. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. Encompass Health’s revenue was up 11.9% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.86 EPS. As a group, equities analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current fiscal year.

Encompass Health Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. The ex-dividend date of this dividend is Thursday, January 2nd. This represents a $0.68 annualized dividend and a dividend yield of 0.75%. Encompass Health’s dividend payout ratio (DPR) is currently 16.43%.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.